Labs / CDMO: development & manufacturing

Reithera
Rome, Italy · reithera.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
ReiThera develops and manufactures viral-vector-based genetic vaccines and advanced therapies. It supports biotech and pharmaceutical programs from early research through clinical and commercial readiness, with sites in Rome and Naples, Italy.
They take quote requests by email.
What they offer
Technology Development
Transforms nucleotide or amino acid sequences and early-stage concepts into functional viral vectors for research, pre-GMP development, or GMP manufacturing.
Vector engineering
Designs, engineers, optimizes, and characterizes viral vectors for vaccines and advanced therapies.
Plasmid design and sequence assembly
Provides codon optimization, transgene design, plasmid construction, and sequence assembly for vector programs.
Recombinant seed generation
Creates recombinant seed material for viral vector development.
R&D-grade vector production
Produces vectors at research grade for early development work.
Pre-GMP seed production
Generates seed material intended for pre-GMP development workflows.
Analytical method development
Develops fit-for-purpose analytical methods and customized analytical strategies for vector programs.
Process Development
Designs and optimizes upstream and downstream workflows for scalable viral vector manufacturing.
GMP Manufacturing
Manufactures viral vectors and ATMPs under GMP for clinical development and commercial production.
Aseptic fill-finish
Provides aseptic filling in EC Grade B facilities with automated and manual options.
Quality System
Supports development and manufacturing under an integrated quality system.
Analytics
Provides analytical development integrated with process development, manufacturing, and quality functions.
What they work on
- Modalities
- Antibody, Viral vector, Vaccine, Plasmid DNA
- Species and models
- HEK293, Duck Embryo Fibroblast-derived production platform, gorilla adenovirus, chimpanzee-derived adenovirus (ChAd)
- Assays and studies
- analytical method development, fit-for-purpose analytical methods, batch release, in-process control
- Instruments and platforms
- 2,000 L bioreactors, 200 L disposable stirred-tank bioreactors, 1,000 L disposable stirred-tank bioreactors, 2,000 L disposable stirred-tank bioreactors, fixed-bed bioreactors, WAVE bioreactors, oRABS Isolator System, Watson-Marlow Flexicon FCP50W Automated Filler
- Scale and capacity
- 2,000 L bioreactor capacity, 870 m² GMP production suites, 400 m² quality control laboratories, 3,470 m² total area, 1,500 m² newly validated expansion area, up to 2 L bulk independent small-scale production area, up to 30 m² cultivation area, up to 3,500 vials per batch
- Therapeutic areas
- infectious diseases, oncology, personalized medicine, cancer immunotherapy
- Turnaround
- rapid vector development
- Type
- CRDMO
- Sites
- Rome, Italy · Naples, Italy
- Quality
- GMP-certified facility · cGMP production suites · Grade B cleanrooms · Grade B/C production rooms · EC Grade B aseptic filling suite · fully compliant with global regulatory s
Public records
- Ownership
- REITHERA S.R.L. · IT GLEIF
Similar labs. AGC Biologics, Minaris, ProBioGen AG, Avid Bioservices
Found in a contract services directory. Listing built from reithera.com. Work here? Claim this listing.